biote Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	3.32	-0.97	32.62	29.16	21.29
Depreciation & Amortization	3.49	2.44	1.63	1.36	1.04
Share-Based Compensation	9.06	82.18	0	0	0
Other Operating Activities	11.02	-92.81	-0.53	-4.09	3.03
Operating Cash Flow	26.88	-9.16	33.72	26.43	25.35
Operating Cash Flow Growth	-	-	27.61%	4.22%	-
Capital Expenditures	-2.71	-1.84	-3.81	-1.39	-1.67
Investing Cash Flow	-2.71	-1.84	-3.81	-1.39	-1.67
Share Issuance / Repurchase	0.56	0.44	0	0	0
Debt Issued / Paid	-6.25	80.34	-5	-5	44.19
Other Financing Activities	-8.69	-17.32	-15.34	-13.32	-57.74
Financing Cash Flow	-14.38	63.46	-20.34	-18.32	-13.55
Exchange Rate Effect	-0.02	0	-0.01	0.01	-0.01
Net Cash Flow	9.77	52.47	9.56	6.72	10.12
Free Cash Flow	24.17	-11	29.91	25.03	23.68
Free Cash Flow Growth	-	-	19.50%	5.70%	-
Free Cash Flow Margin	13.04%	-6.67%	21.46%	21.47%	21.53%
Free Cash Flow Per Share	0.94	-1.36	30.53	25.55	24.17

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).